Your account is not claimed yet. You can sign up with ORCID to claim your account.

Johannes T Reckweg (J Reckweg, J T Reckweg)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Depressive Symptoms

Placebo Controlled

Temporal Lobe Epilepsy

Top Venues

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Journal of neurochemistry

Clinical pharmacology and therapeutics

Translational psychiatry

This page only lists publications with an associated author ORCID identifier.

Publications

Pablo Mallaroni, Natasha L Mason, Johannes T Reckweg, Riccardo Paci, Sabrina Ritscher, Stefan W Toennes, Eef L Theunissen, Kim Paula Colette Kuypers, Johannes G Ramaekers
Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognition. Clinical pharmacology and therapeutics (2023)
Johannes T Reckweg, Malin V Uthaug, Attila Szabo, Alan K Davis, Rafael Lancelotta, Natasha L Mason, Johannes G Ramaekers
The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT). Journal of neurochemistry 162 (1) (2022)
Natasha L Mason, Kim Paula Colette Kuypers, Johannes T Reckweg, F Müller, D H Y Tse, B Da Rios, Stefan W Toennes, P Stiers, A Feilding, Johannes G Ramaekers
Spontaneous and deliberate creative cognition during and after psilocybin exposure. Translational psychiatry 11 (1) (2021)
Natasha L Mason, Kim Paula Colette Kuypers, F Müller, Johannes T Reckweg, D H Y Tse, Stefan W Toennes, N R P W Hutten, J F A Jansen, P Stiers, A Feilding, J G Ramaekers
Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 45 (12) (2020)